Interestingly, neither P1, P2 nor any of the other AD-AID patients previously reported developed clinical autoimmune features, whereas this occurs in at least 25% of the AR-AID deficient patients due to defects in peripheral and central B-cell tolerance [69]. The gene discussed is AICDA; the disease is Alzheimer disease.